Teton Advisors »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Teton Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Teton Advisors from 13F filings

Historical chart of Teton Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Teton Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Teton Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $398k 350k 1.14
2024-06-30 $323k 250k 1.29
2024-03-31 $234k 200k 1.17

More positions owned by Teton Advisors

Ducommun Equity (DCO)
Nathan's Famous Equity (NATH)
Gencor Industries Equity (GENC)
Eastern Co/the Equity (EML)
Distribution Solutions Group Equity (DSGR)
Myers Industries Equity (MYE)
Park-ohio Holdings Corp Equity (PKOH)
Flushing Financial Corp Equity (FFIC)
Gibraltar Industries Equity (ROCK)
Cts Corp Equity (CTS)
Limoneira Equity (LMNR)
Kkr & Co Equity (KKR)
Astec Industries Equity (ASTE)
Astronics Corp Equity (ATRO)
Foster Equity (FSTR)

View all positions for Teton Advisors

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1